ResearcherUniversity of North Carolina at CharlotteNo recent work listed
Megan J Moerdyk-Schauwecker
Matched on ORCID iD 0009-0001-4348-7512; OpenAlex author ID A5019884565. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2012: 1 paper · 2013: 3 papers · 2014: none · 2015: 1 paper · 2016: 1 paper
Papers 6
- Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Co-author DOI 10.18632/oncotarget.11202↗
- Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus. First author DOI 10.1016/j.virol.2014.10.026↗
- Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Co-author DOI 10.1016/j.virol.2012.11.014↗
- Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Co-author DOI 10.1128/jvi.01412-13↗
- Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1128/jvi.02979-12↗
- Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. Co-author DOI 10.1128/jvi.05640-11↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Valery Z. Grdzelishvili · 6 shared papers, 2012–2016 · strength 0.31
- Paper Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus. DOI 10.1016/j.virol.2014.10.026↗
- Paper Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. DOI 10.18632/oncotarget.11202↗
- Paper Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. DOI 10.1016/j.virol.2012.11.014↗
- Sébastien A. Felt · 2 shared papers, 2015–2016 · strength 0.15
- Andrea M. Murphy · 4 shared papers, 2012–2013 · strength 0.15
- Paper Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. DOI 10.1016/j.virol.2012.11.014↗
- Paper Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma DOI 10.1128/jvi.02979-12↗
- Paper Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenoc… DOI 10.1128/jvi.01412-13↗
- Pinku Mukherjee · 4 shared papers, 2012–2013 · strength 0.15
- Paper Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. DOI 10.1016/j.virol.2012.11.014↗
- Paper Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma DOI 10.1128/jvi.02979-12↗
- Paper Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenoc… DOI 10.1128/jvi.01412-13↗
- Eric L. Hastie · 3 shared papers, 2013–2016 · strength 0.15
- Paper Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. DOI 10.18632/oncotarget.11202↗
- Paper Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. DOI 10.1016/j.virol.2012.11.014↗
- Paper Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenoc… DOI 10.1128/jvi.01412-13↗
- Dahlia M. Besmer · 3 shared papers, 2012–2013 · strength 0.11
- Paper Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma DOI 10.1128/jvi.02979-12↗
- Paper Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenoc… DOI 10.1128/jvi.01412-13↗
- Paper Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. DOI 10.1128/jvi.05640-11↗
- Marcela P. Cataldi · 1 shared paper, 2016 · strength 0.07
- Lopamudra Das Roy · 1 shared paper, 2013 · strength 0.03
- Jennifer M. Curry · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.